药明合联:25年业绩强劲增长 全球扩张巩固市场领导力_业绩预览

中金公司
Jan 15

公司预测收入同比增长超过45%公司发布2025 年业绩预告,收入同比增速超过45%、经调整净利润(不含利息收入和支出)同比增长超45%。同时,首席执行官李锦才博士在第44 届摩根大通医疗健康大会上发表演讲,更新长期增长目标:2025-2030 年复合年增长率达30-35%,2030年商业化生产项目与XDC分子营收占比均突破20%。关注要点核心业务保持高速增长,行业龙头地位继续巩固。2025 年,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10